> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Intera Oncology Recalls Hepatic Artery Pump
- URL: https://www.fdaweb.com/intera-oncology-recalls-hepatic-artery-pump/
- Published: 2022-08-29T12:00:00.000Z
- Updated: 2026-09-14T17:57:37.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152616

Intera Oncology has recalled its Intera 3000 Hepatic Artery Infusion Pump after receiving three reports that the pumps were delivering medications (flow rate) faster than expected. “If the pump delivers infusions at faster than expected flow rates, the patient may receive too much medication at one time, resulting in life-threatening hematologic (myelosuppression) toxicity, neurotoxicity, or death,” a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/intera-oncology-recalls-intera-3000-hepatic-artery-infusion-pump-due-faster-expected-flow-rates-may?utm%5Fmedium=email&utm%5Fsource=govdelivery) says. “Additionally, if the flow rate is too fast, the patient may run out of medication before a pump refill occurs, which may allow their disease to progress or lead to death.”

The pump is used to continuously deliver medicine through an artery that supplies blood and oxygen to the liver and several other organs (hepatic artery). It is implanted into adult patients and delivers chemotherapy medications to treat liver tumors.